BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 4:18:00 PM | Browse: 1083 | Download: 1061
 |
Received |
|
2013-02-21 11:18 |
 |
Peer-Review Started |
|
2013-02-22 10:12 |
 |
To Make the First Decision |
|
2013-03-11 15:04 |
 |
Return for Revision |
|
2013-03-17 19:05 |
 |
Revised |
|
2013-05-19 22:13 |
 |
Second Decision |
|
2013-06-03 11:32 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-06-04 08:27 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-07-18 15:07 |
 |
Publish the Manuscript Online |
|
2013-07-25 09:10 |
Category |
Surgery |
Manuscript Type |
Autobiography |
Article Title |
In vivo assessment of intratumoral aspirin injection to treat hepatic tumors
|
Manuscript Source |
Invited Manuscript |
All Author List |
Rogério Saad-Hossne, Fábio Vieira Teixeira and Rafael Denadai |
Funding Agency and Grant Number |
|
Corresponding Author |
Rafael Denadai, MD, Division of Coloproctology, Department of Surgery, Botucatu Medical School, University of the State of São Paulo, Distrito de Rubião Júnior s/n, 18618-000 Botucatu-SP, Brazil. denadai.rafael@hotmail.com |
Key Words |
Intralesional injection; Intratumoral injection; Aspirin; Hepatic tumor; VX2; Rabbit; Antineoplastic; Therapy |
Core Tip |
This experimental study employed the well-established VX2 hepatic tumor rabbit model to assess the antineoplastic efficacy of intratumoral aspirin injection. Analysis of early (24 h post-treatment) and late (7 d post-treatment) effects indicated that the therapy caused early tumor destruction, as evidenced by significant necrotic areas in histopathological analysis, without late recurrence, as demonstrated by hepatic tissue regeneration and restoration of liver function biochemical parameters. |
Publish Date |
2013-07-25 09:10 |
Citation |
Saad-Hossne R, Teixeira FV, Denadai R. In vivo assessment of intratumoral aspirin injection to treat hepatic tumors. World J Hepatol 2013; 5(7): 372-378 |
URL |
http://www.wjgnet.com/1948-5182/full/v5/i7/372.htm |
DOI |
http://dx.doi.org/10.4254/wjh.v5.i7.372 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345